Literature DB >> 14707172

Identification of antibiotic stress-inducible promoters: a systematic approach to novel pathway-specific reporter assays for antibacterial drug discovery.

Hans Peter Fischer1, Nina A Brunner, Bernd Wieland, Jesse Paquette, Ludwig Macko, Karl Ziegelbauer, Christoph Freiberg.   

Abstract

As present antibiotics therapy becomes increasingly ineffectual, new technologies are required to identify and develop novel classes of antibacterial agents. An attractive alternative to the classical target-based approach is the use of promoter-inducible reporter assays for high-throughput screening. The wide usage of these assays is, however, limited by the small number of specifically responding promoters that are known at present. This work describes a novel approach for identifying genetic regulators that are suitable for the design of pathway-specific assays. The basis for the proposed strategy is a large set of antibiotics-triggered expression profiles ("Reference Compendium"). Pattern recognition algorithms applied to the expression data pinpoint the relevant transcription-factor-binding sites in whole-genome sequences. Using this technique, we constructed a fatty-acid-pathway-specific reporter assay that is based on a novel stress-inducible promoter. In a proof-of-principle experiment, this assay was shown to enable screening for new small-molecule inhibitors of bacterial growth.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14707172      PMCID: PMC314284          DOI: 10.1101/gr.1275704

Source DB:  PubMed          Journal:  Genome Res        ISSN: 1088-9051            Impact factor:   9.043


  40 in total

1.  The new antibiotics.

Authors:  H Breithaupt
Journal:  Nat Biotechnol       Date:  1999-12       Impact factor: 54.908

Review 2.  Structure, conformation, and mechanism in the membrane transport of alkali metal ions by ionophoric antibiotics.

Authors:  Frank G Riddell
Journal:  Chirality       Date:  2002 Feb-Mar       Impact factor: 2.437

3.  Unfolding of microarray data.

Authors:  A B Goryachev; P F Macgregor; A M Edwards
Journal:  J Comput Biol       Date:  2001       Impact factor: 1.479

Review 4.  Novel targets for the future development of antibacterial agents.

Authors:  D McDevitt; D J Payne; D J Holmes; M Rosenberg
Journal:  J Appl Microbiol       Date:  2002       Impact factor: 3.772

5.  Global RNA half-life analysis in Escherichia coli reveals positional patterns of transcript degradation.

Authors:  Douglas W Selinger; Rini Mukherjee Saxena; Kevin J Cheung; George M Church; Carsten Rosenow
Journal:  Genome Res       Date:  2003-02       Impact factor: 9.043

6.  Gene expression changes triggered by exposure of Haemophilus influenzae to novobiocin or ciprofloxacin: combined transcription and translation analysis.

Authors:  H Gmuender; K Kuratli; C P Gray; W Keck; S Evers
Journal:  Genome Res       Date:  2001-01       Impact factor: 9.043

7.  Construction of cloning vectors for Bacillus thuringiensis.

Authors:  O Arantes; D Lereclus
Journal:  Gene       Date:  1991-12-01       Impact factor: 3.688

8.  beta-ketoacyl-acyl carrier protein synthase III (FabH) is a determining factor in branched-chain fatty acid biosynthesis.

Authors:  K H Choi; R J Heath; C O Rock
Journal:  J Bacteriol       Date:  2000-01       Impact factor: 3.490

9.  Phylogenetic footprinting of transcription factor binding sites in proteobacterial genomes.

Authors:  L McCue; W Thompson; C Carmack; M P Ryan; J S Liu; V Derbyshire; C E Lawrence
Journal:  Nucleic Acids Res       Date:  2001-02-01       Impact factor: 16.971

10.  Discovery of a novel and potent class of FabI-directed antibacterial agents.

Authors:  David J Payne; William H Miller; Valerie Berry; John Brosky; Walter J Burgess; Emile Chen; Walter E DeWolf; Andrew P Fosberry; Rebecca Greenwood; Martha S Head; Dirk A Heerding; Cheryl A Janson; Deborah D Jaworski; Paul M Keller; Peter J Manley; Terrance D Moore; Kenneth A Newlander; Stewart Pearson; Brian J Polizzi; Xiayang Qiu; Stephen F Rittenhouse; Courtney Slater-Radosti; Kevin L Salyers; Mark A Seefeld; Martin G Smyth; Dennis T Takata; Irene N Uzinskas; Kalindi Vaidya; Nicola G Wallis; Scott B Winram; Catherine C K Yuan; William F Huffman
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

View more
  14 in total

1.  Discovering the mechanism of action of novel antibacterial agents through transcriptional profiling of conditional mutants.

Authors:  C Freiberg; H P Fischer; N A Brunner
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

2.  Novel approach to mapping of resistance mutations in whole genomes by using restriction enzyme modulation of transformation efficiency.

Authors:  Claude G Lerner; Stephan J Kakavas; Christian Wagner; Richard T Chang; Philip J Merta; Xiaoan Ruan; Randy E Metzger; Bruce A Beutel
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

3.  Double recombinant Mycobacterium bovis BCG strain for screening of primary and rationale-based antimycobacterial compounds.

Authors:  Vandana Singh; Rajesh Kumar Biswas; Bhupendra N Singh
Journal:  Antimicrob Agents Chemother       Date:  2013-12-16       Impact factor: 5.191

Review 4.  The challenge of converting Gram-positive-only compounds into broad-spectrum antibiotics.

Authors:  Michelle F Richter; Paul J Hergenrother
Journal:  Ann N Y Acad Sci       Date:  2018-02-15       Impact factor: 5.691

5.  Bioluminescent Reporters for Rapid Mechanism of Action Assessment in Tuberculosis Drug Discovery.

Authors:  Krupa Naran; Atica Moosa; Clifton E Barry; Helena I M Boshoff; Valerie Mizrahi; Digby F Warner
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

6.  Novel whole-cell antibiotic biosensors for compound discovery.

Authors:  Andreas Urban; Stefan Eckermann; Beate Fast; Susanne Metzger; Matthias Gehling; Karl Ziegelbauer; Helga Rübsamen-Waigmann; Christoph Freiberg
Journal:  Appl Environ Microbiol       Date:  2007-08-24       Impact factor: 4.792

7.  Differential gene expression to investigate the effect of (5Z)-4-bromo- 5-(bromomethylene)-3-butyl-2(5H)-furanone on Bacillus subtilis.

Authors:  Dacheng Ren; Laura A Bedzyk; Peter Setlow; Dacre F England; Staffan Kjelleberg; Stuart M Thomas; Rick W Ye; Thomas K Wood
Journal:  Appl Environ Microbiol       Date:  2004-08       Impact factor: 4.792

8.  Target mechanism-based whole-cell screening identifies bortezomib as an inhibitor of caseinolytic protease in mycobacteria.

Authors:  Wilfried Moreira; Grace J Y Ngan; Jian Liang Low; Anders Poulsen; Brian C S Chia; Melgious J Y Ang; Amelia Yap; Justina Fulwood; Umayal Lakshmanan; Jolander Lim; Audrey Y T Khoo; Horst Flotow; Jeffrey Hill; Ravikiran M Raju; Eric J Rubin; Thomas Dick
Journal:  MBio       Date:  2015-05-05       Impact factor: 7.867

9.  Time-resolved transcriptome analysis of Bacillus subtilis responding to valine, glutamate, and glutamine.

Authors:  Bang-Ce Ye; Yan Zhang; Hui Yu; Wen-Bang Yu; Bao-Hong Liu; Bin-Cheng Yin; Chun-Yun Yin; Yuan-Yuan Li; Ju Chu; Si-Liang Zhang
Journal:  PLoS One       Date:  2009-09-18       Impact factor: 3.240

Review 10.  Discovering new bioactive molecules from microbial sources.

Authors:  Paolo Monciardini; Marianna Iorio; Sonia Maffioli; Margherita Sosio; Stefano Donadio
Journal:  Microb Biotechnol       Date:  2014-03-24       Impact factor: 5.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.